Published in Pediatr Infect Dis J on January 01, 2001
Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children | NCT00055107
Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis (2004) 2.70
Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. J Allergy Clin Immunol (2008) 2.01
Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy. Clin Infect Dis (2015) 1.47
Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era. Arch Pediatr Adolesc Med (2009) 1.16
Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children. J Acquir Immune Defic Syndr (2009) 1.11
Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children. Pediatr Infect Dis J (2012) 0.84
Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database. Pediatr Infect Dis J (2014) 0.80
The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis. Thorax (2017) 0.78
Mortality and morbidity patterns among HIV patients with prognostic markers in a tertiary care hospital in southern India. Australas Med J (2011) 0.77
The impact of HIV infection on childhood pneumonia: comparison between developed and developing regions. Malawi Med J (2002) 0.75
Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review. Pediatr Infect Dis J (2014) 0.75
Executive summary: 2013 update of the guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. Pediatr Infect Dis J (2013) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med (1993) 5.67
A nondefective (competent) adenovirus-SV40 hybrid isolated from the AD.2-SV40 hybrid population. Proc Natl Acad Sci U S A (1969) 3.81
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother (1979) 3.61
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. V. Isolation of additional hybrids which differ in their simian virus 40-specific biological properties. J Virol (1973) 2.87
An unusual infection due to staphylococcus aureus. N Engl J Med (1971) 2.68
Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med (1982) 2.37
Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology (1998) 2.26
Rapid detection of respiratory syncytial virus in nasopharyngeal secretions by enzyme-linked immunosorbent assay. J Clin Microbiol (1985) 2.10
Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med (1983) 2.03
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. VII. Characterization of the simian virus 40 RNA species induced by five nondefective hybrid viruses. J Virol (1973) 2.02
Virus-specific nucleic acids in SV40-exposed hamster embryo cell lines: correlation with S and T antigens. Proc Natl Acad Sci U S A (1969) 1.97
Use of subgenomic poliovirus DNA hybridization probes to detect the major subgroups of enteroviruses. J Clin Microbiol (1984) 1.90
Detection of parasite DNA in Chagas' heart disease. Lancet (1995) 1.86
Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med (1994) 1.77
Herpes simplex virus type 1 DNA in cerebrospinal fluid of a patient with Mollaret's meningitis. N Engl J Med (1991) 1.69
Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis (1995) 1.66
Multi-state Markov models for analysing incomplete disease history data with illustrations for HIV disease. Stat Med (1994) 1.62
Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens. Infect Immun (1978) 1.60
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. 3. Base composition, molecular weight, and conformation of the Ad2+ND genome. J Virol (1971) 1.59
Functional analysis of the intergenic regions of TcP2beta gene loci allowed the construction of an improved Trypanosoma cruzi expression vector. Gene (1999) 1.50
Molecular karyotype of clone CL Brener chosen for the Trypanosoma cruzi genome project. Mol Biochem Parasitol (1995) 1.48
Factors affecting the detection of enteroviruses in cerebrospinal fluid with coxsackievirus B3 and poliovirus 1 cDNA probes. J Clin Microbiol (1985) 1.47
Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J Infect Dis (1979) 1.46
Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America. J Clin Microbiol (1999) 1.45
Interferon and transcription of early virus-specific RNA in cells infected with simian virus 40. Proc Natl Acad Sci U S A (1971) 1.43
Virus-specific deoxyribonucleic acid in simian virus 40-exposed hamster cells: correlation with S and T antigens. J Virol (1970) 1.42
PCR-based screening and lineage identification of Trypanosoma cruzi directly from faecal samples of triatomine bugs from northwestern Argentina. Parasitology (2006) 1.42
Interferon inhibits the in vitro accumulation of virus specific RNA in nuclei isolated from SV40 infected cells. Biochem Biophys Res Commun (1977) 1.41
Airborne transmission of chickenpox in a hospital. N Engl J Med (1980) 1.39
Nucleotide cDNA and complete deduced amino acid sequence of a Trypanosoma cruzi ribosomal P protein (P-JL5). Nucleic Acids Res (1990) 1.38
Nonisotopic oligomeric probes for the human enteroviruses. J Clin Microbiol (1988) 1.36
Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis (2012) 1.36
Inhibition of human herpesviruses by combination of acyclovir and human leukocyte interferon. Infect Immun (1981) 1.35
Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children. Pediatrics (2001) 1.33
Alcohol disorders among Asian Americans: associations with unfair treatment, racial/ethnic discrimination, and ethnic identification (the national Latino and Asian Americans study, 2002-2003). J Epidemiol Community Health (2008) 1.30
Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis (1998) 1.27
Development and application of RNA probes for the study of picornaviruses. Mol Cell Probes (1988) 1.27
Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry. Proc Natl Acad Sci U S A (1985) 1.26
In vitro evaluations of condoms with and without nonoxynol 9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus type 2, and human immunodeficiency virus. Sex Transm Dis (1989) 1.25
Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis (1983) 1.24
Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med (1995) 1.23
Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation (2001) 1.23
Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics (1991) 1.21
Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B. J Infect Dis (1977) 1.18
RNA target loss during solid phase hybridization of body fluids--a quantitative study. Mol Cell Probes (1987) 1.18
Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis J (1993) 1.17
Rapid herpes simplex virus susceptibility testing using an enzyme-linked immunosorbent assay performed in situ on fixed virus-infected monolayers. Antimicrob Agents Chemother (1987) 1.16
Clinical application of responder cell frequency estimates with four years of follow up. J Immunol Methods (1994) 1.16
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med (1982) 1.16
Fatal disseminated adenovirus infection in a renal transplant recipient. Am J Med (1975) 1.13
Local EM estimation of the hazard function for interval-censored data. Biometrics (1999) 1.13
Proliferative and interferon responses by peripheral blood mononuclear cells after bone marrow transplantation in humans. Infect Immun (1978) 1.13
In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2. Antimicrob Agents Chemother (1992) 1.13
Expression of the transferrin gene during development of non-hepatic tissues: high level of transferrin mRNA in fetal muscle and adult brain. Biochem Biophys Res Commun (1984) 1.13
Use of an enzyme-linked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against varicella-zoster virus. Antimicrob Agents Chemother (1985) 1.13
Neonatal adenovirus infection: four patients and review of the literature. Pediatrics (1991) 1.12
Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res (1997) 1.12
The 70-kDa heat-shock protein is a major antigenic determinant in human Trypanosoma cruzi/Leishmania braziliensis braziliensis mixed infection. Immunol Lett (1992) 1.11
Humoral autoimmune response to ribosomal P proteins in chronic Chagas heart disease. Clin Exp Immunol (1991) 1.11
Major Trypanosoma cruzi antigenic determinant in Chagas' heart disease shares homology with the systemic lupus erythematosus ribosomal P protein epitope. J Clin Microbiol (1990) 1.11
Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation. Am J Transplant (2007) 1.11
Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc Natl Acad Sci U S A (1997) 1.10
Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group. Arch Intern Med (1997) 1.09
Incidence of herpes zoster in patients with altered immune function. Infection (2013) 1.09
Oral ribavirin therapy for subacute sclerosing panencephalitis. J Infect Dis (1989) 1.08
Clinical practice guidelines for the management of chronic sinusitis in children. Otolaryngol Head Neck Surg (1999) 1.08
Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease. J Immunol (1996) 1.08
Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic. FASEB J (2001) 1.05
Trypanosoma cruzi: antibodies to a MAP-like protein in chronic Chagas' disease cross-react with mammalian cytoskeleton. Exp Parasitol (1991) 1.04
Long-term reduction of Trypanosoma cruzi infection in sylvatic mammals following deforestation and sustained vector surveillance in northwestern Argentina. Acta Trop (2006) 1.04
Replication strand preference for deletions associated with DNA palindromes. Mol Microbiol (1998) 1.04
Herpes simplex meningitis: isolation of herpes simplex virus type 2 from cerebrospinal fluid. N Engl J Med (1973) 1.03
Characterization of the human newborn response to herpesvirus antigen. J Immunol (1985) 1.02
Effect of acyclovir on the proliferation of human fibroblasts and peripheral blood mononuclear cells. Antimicrob Agents Chemother (1980) 1.01
Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol (1994) 1.01
Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group. Antimicrob Agents Chemother (1991) 0.99
Confirmatory testing of Rotazyme results in neonates. J Pediatr (1985) 0.99
Neonatal rotavirus-associated necrotizing enterocolitis: case control study and prospective surveillance during an outbreak. J Pediatr (1988) 0.98
Use of bone marrow fibroblasts to prepare targets for an HLA restricted-cytotoxicity assay system. J Clin Microbiol (1984) 0.97
Varicella-zoster virus infection of human astrocytes, Schwann cells, and neurons. Virology (1990) 0.96
Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease. Clin Exp Immunol (2007) 0.96
Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant (2006) 0.96
Lack of correlation between infection with reovirus 3 and extrahepatic biliary atresia or neonatal hepatitis. J Pediatr (1988) 0.95
Early diagnosis of recurrence of Trypanosoma cruzi infection by polymerase chain reaction after heart transplantation of a chronic Chagas' heart disease patient. J Heart Lung Transplant (2000) 0.94
Factors influencing quantitative isolation of varicella-zoster virus. J Clin Microbiol (1984) 0.94
Immune responses to varicella zoster virus infections in healthy children. J Infect Dis (1993) 0.94
Viral pneumonia in the first month of life. Pediatr Infect Dis J (1990) 0.93
Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England. Neurology (2001) 0.93
Infection of human peripheral blood mononuclear cells by varicella-zoster virus. Intervirology (1982) 0.92
Gamma interferon production by combinations of human peripheral blood lymphocytes, monocytes, and cultured macrophages. Infect Immun (1982) 0.92
Transplacental passage of influenza A/Bangkok (H3N2) mimicking amniotic fluid infection syndrome. Am J Obstet Gynecol (1984) 0.91
Immunization with recombinant Trypanosoma cruzi ribosomal P2beta protein induces changes in the electrocardiogram of immunized mice. FEMS Immunol Med Microbiol (1997) 0.91
Structural basis of the cross-reaction between an antibody to the Trypanosoma cruzi ribosomal P2beta protein and the human beta1 adrenergic receptor. FASEB J (2006) 0.91
Intracellular detection of sense and antisense enteroviral RNA by in situ hybridization. J Virol Methods (1988) 0.91
Natural killer cell activity in multiple sclerosis. J Immunol (1981) 0.90